VBI Vaccines Inc reports results for the quarter ended in December - Earnings Summary

VBI Vaccines

07/03/2022 14:33

* VBI Vaccines Inc  VBIV.OQ  reported a quarterly adjusted
loss
of 7 cents​​ per share for the quarter ended in December. The
mean expectation of three analysts for the quarter was for a
loss of 7 cents per share.
    * Revenue fell 50.6% to $81.00 thousand from a year ago; 
analysts
expected $137.33 thousand. 
    * VBI Vaccines Inc's reported EPS for the quarter was a loss
of 7
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * VBI Vaccines Inc shares had fallen by 44.0% this quarter.
    * The company reported a quarterly loss of $18.78 million.
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $8.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 7 at 02:33 p.m.  ​All
figures in US dollars unless otherwise stated